Lithium Orotate: The Definitive Guide

What is lithium orotate?

Lithium orotate is the lithium salt of orotic acid. Retail products may state the total compound mass or the elemental lithium supplied by that compound. Those numbers are not interchangeable: an overdose report calculated 3.83 mg elemental lithium per 100 mg lithium orotate for the product described. [7]

No major dietary reference establishes lithium as an essential human nutrient, and no RDA, AI or UL exists. Prescription lithium carbonate is an evidence-based medicine for specific psychiatric indications with serum, kidney and thyroid monitoring. Lithium orotate has not inherited that efficacy evidence merely because both compounds deliver lithium ions.

Typical Lithium Orotate Protocols

The old alcohol-use report was not randomized, did not use a concurrent control, selected 42 people from 105 who began treatment, and combined lithium orotate with a diet, optional mineral orotates, bromelain, phospholipids and supportive care. Its 150 mg compound amount is not a validated routine dose. [2]

The two modern registries show that investigators still treat formulation, tolerability, serum exposure, kidney function and thyroid function as open questions. Neither supplies completed efficacy results as of the review date. [10], [11]

Should lithium orotate be cycled?

No cycling schedule has been validated. Intermittent use does not erase renal handling, interaction or cumulative-exposure questions.

What happens when it is stopped?

There is no characterized lithium-orotate withdrawal syndrome. Stopping prescribed lithium can carry relapse risk and belongs with the prescriber; supplement guidance must not be substituted for psychiatric medication management.

Which foods contain lithium?

Trace lithium occurs in water and foods, with geography-dependent exposure. Population correlations and food-water measurements do not establish an individual deficiency diagnosis, a target intake or a lithium-orotate dose.

Which forms and labels matter?

Lithium orotate compound mass includes lithium plus the orotate portion. Elemental lithium is the lithium ion amount. A label saying “Lithium 5 mg (as lithium orotate)” generally declares 5 mg elemental lithium; a label saying “lithium orotate 5 mg” may describe only 5 mg of the whole salt. The Supplement Facts syntax and manufacturer specification are necessary to tell which.

Lithium carbonate, lithium citrate, lithium-rich brewer's yeast and lithium orotate are distinct preparations. Human efficacy from prescription lithium or nutritional yeast cannot be reassigned to lithium orotate.

How should it be stored?

Keep the container sealed, dry and out of children's reach. Retain the full label and lot number; the front-panel phrase “low dose” does not identify elemental lithium.

What is lithium orotate commonly used for?

Marketing commonly targets mood, stress, alcohol cravings, sleep and cognitive ageing. Completed human evidence specific to lithium orotate does not establish any of those uses. The 1994 randomized mood study used lithium-rich brewer's yeast, not orotate. [3]

What does human research show?

Human lithium-orotate evidence

The 1986 Sartori paper reviewed private-practice records for 42 alcohol-rehabilitation patients who remained on a combined program for at least six months. They came from 105 people who began treatment. There was no randomized comparator, cointerventions varied, follow-up was retrospective, and eight reported muscle weakness, appetite loss or mild apathy. The report cannot isolate lithium orotate or prove relapse prevention. [2]

A separate randomized study enrolled 24 former drug users and supplied 400 mcg/day of lithium through lithium-rich brewer's yeast for four weeks. It reported questionnaire improvement, but it did not test lithium orotate, was small and used a narrow selected population. [3]

MixLi is an ongoing single-arm feasibility study, and LiO-AD was not yet recruiting on October 9, 2026. Registered protocols are useful for showing planned exposure and monitoring; they are not results. [10], [11]

Alzheimer research

Aron and colleagues measured metals in postmortem human brain and found lower prefrontal-cortex lithium in mild cognitive impairment and Alzheimer disease. Treatment experiments then occurred in mice: dietary depletion worsened Alzheimer-like pathology, while low-dose lithium orotate in drinking water reduced pathology and memory loss in mouse models. The paper supports a human hypothesis and animal mechanism, not prevention or treatment efficacy in people. [1]

Pharmacokinetics and toxicology

The animal literature is internally inconsistent. A 1976 rat study found no meaningful uptake, distribution or excretion difference among orotate, carbonate and chloride after matched lithium exposures. [4] A 1978 injection study reported higher serum and brain lithium with orotate. [5] A 1979 replication linked higher tissue concentrations to impaired kidney function after a high intraperitoneal exposure. [6]

A 2021 test battery found no genotoxic signal and no identified target-organ toxicity in rats given 100, 200 or 400 mg/kg/day lithium orotate by gavage for 28 days. That study supplies a short-term animal toxicology boundary. It cannot establish a chronic human no-effect dose, kidney safety in susceptible people or a conversion for self-treatment. [8]

How might lithium work?

Lithium ions affect enzymes and signaling pathways including GSK3. These mechanisms are shared across lithium salts after lithium becomes bioavailable. Claims that the orotate carrier selectively delivers lithium to the brain remain unresolved in humans; older rat studies produced conflicting distribution and renal findings. [4]–[6]

What are the risks and interactions?

An 18-year-old who intentionally took 18 tablets labeled as 120 mg lithium orotate each developed nausea, vomiting and tremor. Serum lithium rose from 0.31 to 0.40 mEq/L during observation before symptoms resolved with supportive care. The report demonstrates bioavailable lithium and acute toxicity potential, even though it does not define risk from ordinary use. [7]

Prescription labeling is not a lithium-orotate trial, but it establishes how lithium ions can become hazardous. Reduced kidney function, dehydration, fever, heavy sweating, diarrhea and changes in sodium intake can reduce tolerance or raise lithium exposure. Lithium can affect kidney concentrating ability and thyroid function. Pregnancy and breastfeeding require specialist management. [9]

Legal and regulatory status: In the United States, FDA has issued warning letters when lithium-orotate products were promoted to treat diseases; supplement sale does not authorize bipolar, depression or Alzheimer treatment claims. [13] In Canada, the current Natural Health Products Ingredients Database classifies lithium orotate as Non-NHP; Health Canada has also warned about unauthorized products containing it. [12], [14]

Which medicines interact with lithium exposure?

Review NSAIDs such as ibuprofen or naproxen, thiazide and other diuretics, ACE inhibitors, ARBs, metronidazole and other kidney-active medicines. Serotonergic medicines raise a separate serotonin-syndrome concern with prescription lithium, and concurrent prescribed lithium would duplicate exposure. Do not change medicines, salt intake or hydration to accommodate a supplement. [9]

What should be monitored?

No validated test diagnoses “low nutritional lithium.” In supervised lithium treatment, clinicians use symptoms, medication and hydration review, serum lithium timed to the dosing context, kidney function, electrolytes, thyroid function and sometimes calcium. A consumer supplement dose does not make those safety domains irrelevant, while a single low serum result cannot by itself prove safety. [9]

Seek urgent poison-control or emergency guidance after an overdose or with worsening tremor, repeated vomiting or diarrhea, marked drowsiness, confusion, poor coordination, muscle twitching, seizure or collapse.

What do public communities report?

People discuss mood, calmness, sleep and microdosing. Posts often blur compound mass with elemental lithium and rarely include kidney function, sodium balance or interacting medicines. This overhaul did not independently recrawl or quantify community posts.

How does lithium orotate compare with nearby guides?

Common questions about lithium orotate

Is lithium an essential nutrient?

Human essentiality and a dietary requirement are not established. There is no RDA, AI or UL.

Is lithium orotate the same as prescription lithium?

No. It is a different salt and is sold in different amounts and regulatory contexts. Both can deliver lithium ions, so interaction and toxicity concerns cannot be dismissed.

Does 5 mg on a label mean 5 mg elemental lithium?

Only if the Supplement Facts panel declares “Lithium 5 mg” and identifies orotate as the source. “Lithium orotate 5 mg” may mean 5 mg of the entire compound.

Did the 2025 Nature study treat people with lithium orotate?

No. Human brain tissue was observational; lithium-orotate treatment experiments were in mice. [1]

Is there a proven mood dose?

No lithium-orotate dose has established mood efficacy in a modern controlled trial. The randomized 400 mcg study used lithium-rich yeast, not orotate. [3]

Does short-term rat toxicology prove long-term safety?

No. A 28-day rat study cannot establish chronic human safety or a safe self-treatment dose. [8]

Can lithium orotate replace prescribed lithium?

No. Substitution could destabilize psychiatric treatment and remove the monitoring used with prescription lithium.

Is lithium orotate a licensed natural health product in Canada?

Health Canada's ingredient database classifies it as Non-NHP. [12]

Glossary

Plain explanations of lithium-orotate terms.

Elemental lithium

The amount of lithium ion, separate from the mass of its salt or carrier.

Lithium orotate

A salt formed from lithium and orotic acid.

Compound or salt mass

The total weight of lithium plus the orotate portion.

Serum lithium

Lithium concentration in blood, interpreted with timing, symptoms and clinical context.

GSK3

A signaling enzyme affected by lithium and studied in mood and neurodegeneration research.

Non-NHP

A Health Canada ingredient role indicating the substance is not accepted as a natural-health-product ingredient.

Feasibility study

A study testing whether a larger trial can be run; it does not by itself establish efficacy.

How this guide was researched

This draft uses the 2025 Nature paper, the two published human low-dose reports, three primary rat comparisons, a rat toxicology study, a human overdose report, current trial registries, official prescription labeling and regulator records. Live NCBI metadata and CommentsCorrections fields were checked on October 9, 2026; none of the nine PubMed records used here contained a correction relation.

How this guide was made

Research and drafting were AI-assisted. This draft awaits Doserly editorial and independent clinical review. Read the editorial policy.

Explore the sources